Search Results 1501-1510 of 17033 for monoclonal antibody

1. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   The purpose of this study is to evaluate immunogenicity of the vaccine, assessed at week 12, based on the increase in IgG anti-MUC1 antibody titer over the ...

2. Publications - Linda B. Baughn, Ph.D. - Mayo Clinic

   Senescence profiling of monoclonal gammopathies reveals paracrine senescence as a crucial defense against disease progression. Leukemia. 2025 May; 39 (5): ...

3. A Study to Evaluate the Effectiveness of M7824 Monotherapy in Locally Advanced or Metastatic Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - Mayo Clinic

   ... antibodies. Prior therapy with any antibody or inhibitors targeting the TGF-β/TGF-β receptor pathway. Anticancer treatment within 21 days before the start ...

4. Clinical Trials - TD-1473 for Active Ulcerative Colitis (UC)

   Subjects with positive hepatitis B virus core antibody are excluded only if they have concurrent negative hepatitis B surface antibody or detectable serum ...

5. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

   Positive test result for Hepatitis B surface antigen (HBsAg) or positive human immunodeficiency virus (HIV) antibody (confirmed by Western Blot). Any ...

6. Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies - Mayo Clinic

   ... antibody therapy. Radiation therapy within 3 weeks prior to first dose. Radioimmunotherapy within 8 weeks prior to first dose. Localized radiation therapy ...

7. Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183) - Mayo Clinic

   ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell costimulation or checkpoint pathways); Is pregnant or breast ...

8. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Known active hepatitis infection, positive hepatitis C virus (HCV) antibody, hepatitis B virus (HBV) surface antigen (HBsAg) or HBV core antibody (anti-HBc), at ...

9. Stool DNA test - Mayo Clinic

   Learn about this noninvasive colon cancer screening test that can detect DNA changes in cells collected from a stool sample.

10. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...